|
|
Intensive Statin Therapy Benefits Bypass Patients With Acute Coronary Syndrome
|
| Link ID |
9940 |
| Title |
Intensive Statin Therapy Benefits Bypass Patients With Acute Coronary Syndrome |
| Url |
http://www.medscape.com/viewarticle/582418?src=rss |
| Description |
Patients presenting with acute coronary syndrome who have previously had coronary artery bypass surgery (CABG) benefit from intensive statin treatment, according to a meta-analysis of two major trials, the Pravastatin or Atorvastatin Evaluation and Infection Therapy (PROVE-IT), and the Aggrastat to Zocor (A to Z) trial. Reuters Health Information |
| Category |
Articles > Pharmacists |
| Keywords |
|
| Date |
Oct 24, 2008 |
| Contact Name |
|
| Email |
|
Write a Review
Add to My Favorite
Refer it to Friend
Report Broken Link
|
|
Other links at Articles > Pharmacists |
| 1. |
High-Dose Epirubicin for Breast Cancer Provides No Overall Benefit
|
|
|
High-dose epirubicin with cyclophosphamide provides longer event-free survival than does a low-dose approach as adjuvant chemotherapy for node-positive breast cancer. However, the regimen is more cardiotoxic than is standard oral cyclophosphamide, methotrexate, and fluorouracil (CMF) and the outcome is not superior, according to European researchers. Reuters Health Information
|
|
|
